HB 1135, legislation related to PBMs and transparency in the pricing of prescription drugs, passed the House (62-5) on February 13. It was referred to the Senate and Health and Human Services Committee.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy distributed its October 2022 newsletter. Below is an outline of the content.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy published its January 2022 Newsletter, including information about the new Prescription Drug Monitoring Program NarxCare Report called “Tile View”, an update on the drug take-back program, and other information of interest to pharmacies and pharmacists.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy published its July 2021 Newsletter. Highlights include information from the PDMP Director with recommendations to follow if a prescription is suspected of being fraudulent and with information to access Nebraska data. Please recall that the board announced on April 14 that interstate data sharing was established with Nebraska.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Health is holding weekly calls for immunizers each Tuesday at 1 pm. For more information, please join the listserve.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
The Department of Social Services issued a bulletin indicating that Medicaid now allows prescriptions for certain generic maintenance medications to be filled as a 90-day supply. They provided a list of eligible medications, recommending providers to check it regularly as the list is subject to change. Recipients must first establish compliance and tolerability of the medication before it can be filled as a 90-day supply. To qualify, a recipient must have filled the prescription for the same drug and strength for three 30-day supplies within the previous 100 days.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
The Department of Health and Social Services announced a new statewide standing order issued by Mary S. Carpenter, M.D., for Naloxone distribution from pharmacies. Per the standing order, Naloxone can now be requested and dispensed by pharmacists in South Dakota to any person who is an individual at risk of experiencing an opioid-related overdose and/or a family member, friend, or close third-party to a person at risk of experiencing an opioid-related overdose. Detailed information and supporting documents and forms regarding the standing order and Naloxone distribution can be found by accessing www.AvoidOpioidSD.com/pharmacy. For further questions, please contact the SD DSS, Division of Behavioral Health at avoidopioid@state.sd.us, or call 605-367-5236.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
The Board of Pharmacy shared an announcement that there is now a statewide standing order for naloxone distribution from pharmacies. Through a standing order issued by Mary S. Carpenter, MD, with the Departments of Health and Social Services, Naloxone can now be requested and dispensed by pharmacists in South Dakota to any person who is: an individual at risk of experiencing an opioid-related overdose; and/or a family member, friend, or close third party to a person at risk of experiencing an opioid-related overdose. Detailed information and supporting documents and forms regarding the standing order and Naloxone distribution can be found by accessing here.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.
The Board of Pharmacy issued a final rule regarding the licensing and oversight of pharmacists, pharmacy interns, registered pharmacy technicians, and pharmacies, including central fill pharmacies. The rule is effective October 12, 2020.
Also in South Dakota. The Board of Pharmacy has published revised policy statements on pharmacist testing for COVID-19 and for transferring prescriptions. Please use the above links for more information.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.